Except for PDAC, the overexpression of GPC1 has been observed in the tumor tissues of gliomas, ameloblastomas, prostate cancer and esophageal squamous cell carcinoma (ESCC) 7, 33, 34, 35, 36, 37. This evidence concerns the gene GPC1 and prostate cancer.